FDA Inspection 1251525 - Nucrogene Inc - October 09, 2024

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nucrogene Inc

Record Details

This FDA Inspection record concerns Nucrogene Inc, with an inspection on October 9, 2024, issued by the New Jersey District Office, covering human drugs.

Company: Nucrogene Inc
Inspection Date: October 9, 2024
Product Type: Human Drugs
Office: New Jersey District Office

Open in Dashboard

ID · ac1943d8-fea6-435e-b352-f4607b837c74

Violation Codes4

21 CFR 211.166(a)21 CFR 211.180(e)21 CFR 211.67(a)21 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.